Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MPI | P34949 | 1/20 | 0.78 |
| ▸ | PGD | P52209 | 3/20 | 0.50 |
| ▸ | PGK1 | P00558 | 1/20 | 0.44 |
| ▸ | PGK2 | P07205 | 1/20 | 0.44 |
| ▸ | S1PR4 | O95977 | 2/20 | 0.36 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.36 |
| ▸ | S1PR3 | Q99500 | 2/20 | 0.36 |
| ▸ | S1PR5 | Q9H228 | 2/20 | 0.36 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | TSPO | P30536 | 1/20 | 0.36 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.36 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.36 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9741443 | 1.00 | MPI (0.78) | MPIPGDPGK1PGK2S1PR4 | |
| SCHEMBL850111 | 1.00 | MPI (0.78) | MPIPGDPGK1PGK2S1PR4 | |
| SCHEMBL939515 | 1.00 | MPI (0.78) | MPIPGDPGK1PGK2S1PR4 | |
| SCHEMBL9738232 | 1.00 | MPI (0.78) | MPIPGDPGK1PGK2S1PR4 | |
| SCHEMBL9736731 | 1.00 | MPI (0.78) | MPIPGDPGK1PGK2S1PR4 | |
| SCHEMBL321875 | 1.00 | MPI (0.78) | MPIPGDPGK1PGK2S1PR4 | |
| SCHEMBL9737704 | 1.00 | MPI (0.78) | MPIPGDPGK1PGK2S1PR4 | |
| Ammonia Solution, Strong SCHEMBL638028 | 0.98 | MPI (0.75) | MPIPGDPGK1PGK2S1PR4 | |
| Water SCHEMBL22390105 | 0.98 | MPI (0.75) | MPIPGDPGK1PGK2S1PR4 | |
| SCHEMBL10435219 | 0.98 | MPI (0.75) | MPIPGDPGK1PGK2S1PR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 7112 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122075713-A | Deaminase and use of transaminase in the treatment of polyglutamine diseases | — | 2026-05-26 | — | — | CN | claimed |
| EP-4743568-A1 | INCREASED PRODUCTION OF ACETYL-COENZYME A AND DERIVED PRODUCTS IN YEASTS | DANSTAR FERMENT AG (CH) | 2026-05-20 | — | — | EP | claimed |
| WO-2026102434-A1 | USES OF PURINE NUCLEOSIDASE AND AMP PHOSPHORYLASE | CODEXIS, INC. (US) | 2026-05-15 | — | — | WO | claimed |
| EP-3869192-B1 | METHOD FOR QUANTITATIVE DETECTION OF VARIOUS METABOLITES IN BIOLOGICAL SAMPLE | HUMAN METABOLOMICS INST INC (CN) | 2026-05-13 | — | — | EP | claimed |
| EP-4348241-B1 | SEPARATION OF NUCLEIC ACID COMPONENT COMPOUNDS ON ZWITTERIONIC STATIONARY PHASES | WATERS TECHNOLOGIES CORP (US) | 2026-04-29 | — | — | EP | claimed |
| US-20260092179-A1 | GENETICALLY MODIFIED HOST CELLS PRODUCING VIOLACEIN, ANALOGUES, AND DERIVATIVES THEREOF | OCTARINE BIO APS (DK) | 2026-04-02 | — | — | US | claimed |
| US-12584159-B2 | Separation of nucleic acid component compounds on zwitterionic stationary phases | WATERS TECHNOLOGIES CORPORATION (US) | 2026-03-24 | — | — | US | claimed |
| US-20260063623-A1 | METHODS OF ASSESSING METABOLIC FLUX | UNIV MICHIGAN REGENTS (US) | 2026-03-05 | — | — | US | claimed |
| EP-4692364-A1 | METHOD FOR PRODUCING SUBSTANCE | Mitsubishi Chemical Corporation (JP) | 2026-02-11 | — | — | EP | claimed |
| US-20260035705-A1 | ENGINEERED MICROORGANISMS WITH G3P ->3PG ENZYME AND/OR FRUCTOSE-1,6-BISPHOSPHATASE INCLUDING THOSE HAVING SYNTHETIC OR ENHANCED METHYLOTROPHY | AGAIN BIO APS (DK) | 2026-02-05 | — | — | US | claimed |
| EP-0170257-B1 | PROCESS FOR PRODUCING L-TRYPTOPHAN | AJINOMOTO CO., INC. (JP) | 1992-04-15 | — | — | EP | claimed |
| US-5075225-A | PROCESS FOR THE ENZYMATIC SYNTHESIS OF NUCLEOSIDES | THE TEXAS A&M UNIVERSITY SYSTEM (US) | 1991-12-24 | — | — | US | claimed |
| WO-1991009604-A1 | A PHARMACEUTICAL COMPOSITION COMPRISING A PHOSPHOSUGAR | PERSTORP AB (SE) | 1991-07-11 | — | — | WO | claimed |
| US-5004810-A | Herpes simplex virus | SCHERING CORPORATION (US) | 1991-04-02 | — | — | US | claimed |
| EP-0391592-A1 | Process for the enzymatic synthesis of nucleosides | THE TEXAS A & M UNIVERSITY SYSTEM (US) | 1990-10-10 | — | — | EP | claimed |
| US-4885245-A | CONTACTING GENETICALLY ENGINEERED CORYNEFORM BACTERIUM WITH APPROPRIATE RAW MATERIALS | AJINOMOTO CO., INC. (JP) | 1989-12-05 | — | — | US | claimed |
| EP-0170257-A2 | Process for producing l-tryptophan | AJINOMOTO CO., INC. (JP) | 1986-02-05 | — | — | EP | claimed |
| US-4411995-A | Synthesis of nicotinamide cofactors | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1983-10-25 | — | — | US | claimed |
| US-4291023-A | Method for treating tumors using cis-diammineplatinum (II) organophosphate complexes | ENGELHARD MINERALS & CHEMICALS CORP. (US) | 1981-09-22 | — | — | US | claimed |
| US-4234499-A | Cis-diammireplatinum(II) organophosphate complexes | ENGELHARD MINERALS & CHEMICALS CORPORATION (US) | 1980-11-18 | — | — | US | claimed |